332 related articles for article (PubMed ID: 26292038)
21. The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: conditional survival analysis.
Abdollah F; Suardi N; Capitanio U; Matloob R; Fossati N; Castiglione F; Di Trapani E; Di Trapani D; Russo A; Carenzi C; Montorsi F; Rigatti P; Bertini R
Urol Oncol; 2014 Jan; 32(1):43.e9-16. PubMed ID: 23911684
[TBL] [Abstract][Full Text] [Related]
22. Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses.
Weight CJ; Larson BT; Fergany AF; Gao T; Lane BR; Campbell SC; Kaouk JH; Klein EA; Novick AC
J Urol; 2010 Apr; 183(4):1317-23. PubMed ID: 20171688
[TBL] [Abstract][Full Text] [Related]
23. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.
Lerner SE; Hawkins CA; Blute ML; Grabner A; Wollan PC; Eickholt JT; Zincke H
J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276
[TBL] [Abstract][Full Text] [Related]
24. Cryoablation Predisposes to Higher Cancer Specific Mortality Relative to Partial Nephrectomy in Patients with Nonmetastatic pT1b Kidney Cancer.
Pecoraro A; Palumbo C; Knipper S; Mistretta FA; Tian Z; Shariat SF; Saad F; Briganti A; Fiori C; Porpiglia F; Karakiewicz PI
J Urol; 2019 Dec; 202(6):1120-1126. PubMed ID: 31347950
[TBL] [Abstract][Full Text] [Related]
25. Outcomes following partial nephrectomy by tumor size.
Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
[TBL] [Abstract][Full Text] [Related]
26. Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older.
Lane BR; Abouassaly R; Gao T; Weight CJ; Hernandez AV; Larson BT; Kaouk JH; Gill IS; Campbell SC
Cancer; 2010 Jul; 116(13):3119-26. PubMed ID: 20564627
[TBL] [Abstract][Full Text] [Related]
27. Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma.
Higgins MI; Martini DJ; Patil DH; Nabavizadeh R; Steele S; Williams M; Joshi SS; Narayan VM; Sekhar A; Psutka SP; Ogan K; Bilen MA; Master VA
Cancer; 2021 Jun; 127(12):1974-1983. PubMed ID: 33760232
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Significance of Sarcopenia in Patients with Metastatic Renal Cell Carcinoma.
Fukushima H; Nakanishi Y; Kataoka M; Tobisu K; Koga F
J Urol; 2016 Jan; 195(1):26-32. PubMed ID: 26292042
[TBL] [Abstract][Full Text] [Related]
29. Can partial nephrectomy preserve renal function and modify survival in comparison with radical nephrectomy?
Medina-Polo J; Romero-Otero J; Rodríguez-Antolín A; Domínguez-Esteban M; Passas-Martínez J; Villacampa-Aubá F; Lora-Pablos D; Gómez De La Cámara A; Díaz-González R
Scand J Urol Nephrol; 2011 Mar; 45(2):143-50. PubMed ID: 21247272
[TBL] [Abstract][Full Text] [Related]
30. Ipsilateral adrenalectomy at the time of radical nephrectomy impacts overall survival.
Yap SA; Alibhai SM; Abouassaly R; Timilshina N; Margel D; Finelli A
BJU Int; 2013 Mar; 111(3 Pt B):E54-8. PubMed ID: 23039377
[TBL] [Abstract][Full Text] [Related]
31. Partial and radical nephrectomy provide comparable long-term cancer control for T1b renal cell carcinoma.
Meskawi M; Becker A; Bianchi M; Trinh QD; Roghmann F; Tian Z; Graefen M; Perrotte P; Karakiewicz PI; Sun M
Int J Urol; 2014 Feb; 21(2):122-8. PubMed ID: 23819700
[TBL] [Abstract][Full Text] [Related]
32. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
[TBL] [Abstract][Full Text] [Related]
33. Elevated preoperative C-reactive protein is associated with renal functional decline and non-cancer mortality in surgically treated renal cell carcinoma: analysis from the INternational Marker Consortium for Renal Cancer (INMARC).
Cotta BH; Meagher MF; Patil D; Saito K; Patel SH; Patel DN; Miller N; Dutt R; Keiner C; Bradshaw AW; Wan F; Eldefrawy A; Yasuda Y; Fujii Y; Master V; Derweesh IH
BJU Int; 2021 Mar; 127(3):311-317. PubMed ID: 32772468
[TBL] [Abstract][Full Text] [Related]
34. Sarcopenia and systemic inflammation are associated with decreased survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.
Khan AI; Psutka SP; Patil DH; Hong G; Williams MA; Bilen MA; Sekhar A; Kissick HT; Narayan VM; Joshi SS; Ogan K; Master VA
Cancer; 2022 Jun; 128(11):2073-2084. PubMed ID: 35285950
[TBL] [Abstract][Full Text] [Related]
35. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
[TBL] [Abstract][Full Text] [Related]
36. Impact of Perioperative Infection on Cancer Specific Survival after Nephrectomy for Renal Cell Carcinoma.
Tallman JE; Pearce SM; Kuchta K; Helfand BT; Eggener SE
J Urol; 2017 Nov; 198(5):1027-1032. PubMed ID: 28551443
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for acute kidney injury after radical nephrectomy and inferior vena cava thrombectomy for renal cell carcinoma.
Shin S; Han Y; Park H; Chung YS; Ahn H; Kim CS; Cho YP; Kwon TW
J Vasc Surg; 2013 Oct; 58(4):1021-7. PubMed ID: 23591189
[TBL] [Abstract][Full Text] [Related]
38. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.
Bianchi M; Gandaglia G; Trinh QD; Hansen J; Becker A; Abdollah F; Tian Z; Lughezzani G; Roghmann F; Briganti A; Montorsi F; Karakiewicz PI; Sun M
Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864
[TBL] [Abstract][Full Text] [Related]
39. The prognostic value of erythrocyte polyamine in the post-nephrectomy stratification of renal cell carcinoma specific mortality.
Bigot P; Lughezzani G; Karakiewicz P; Perrotte P; Rioux-Leclercq N; Catros-Quemener V; Bouet F; Moulinoux JP; Cipolla B; Patard JJ
J Urol; 2010 Feb; 183(2):486-91. PubMed ID: 20006872
[TBL] [Abstract][Full Text] [Related]
40. Patient and pathologic correlates with perioperative and long-term outcomes of laparoscopic radical nephrectomy.
Gabr AH; Gdor Y; Strope SA; Roberts WW; Wolf JS
Urology; 2009 Sep; 74(3):635-40. PubMed ID: 19616826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
